Literature DB >> 14529418

Safety and utilization of blood components as therapeutic delivery systems.

Tiffany Adams1, Fars Alanazi, D Robert Lu.   

Abstract

In recent years, natural blood components have been extensively studied as the advanced therapeutic delivery systems. The blood components which can potentially be used as the therapeutic delivery systems include different types of cells, such as erythrocytes and lymphocytes, macromolecular complexes such as lipoproteins and antibody or albumin conjugates and other molecules. This review article covers the progress in this topic, specifically, including the safety issues and the utilization of these component. It can be seen through the literature that the blood components as the therapeutic delivery systems have a number of advantages over traditional pharmaceutical products. The efficacy and practice of the applications, however, require significant amount of development work in the near future.

Mesh:

Substances:

Year:  2003        PMID: 14529418     DOI: 10.2174/1389201033489720

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  2 in total

1.  Characterization of diadzein-hemoglobin binding using optical spectroscopy and molecular dynamics simulations.

Authors:  Bidisha Sengupta; Sandipan Chakraborty; Maurice Crawford; Jasmine M Taylor; Laura E Blackmon; Pradip K Biswas; Wolfgang H Kramer
Journal:  Int J Biol Macromol       Date:  2012-05-16       Impact factor: 6.953

Review 2.  Co-opting biology to deliver drugs.

Authors:  Parisa Yousefpour; Ashutosh Chilkoti
Journal:  Biotechnol Bioeng       Date:  2014-07-21       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.